Boris Sepesi researcher
Sepesi, Boris
VIAF ID: 315217790 (Personal)
Permalink: http://viaf.org/viaf/315217790
Preferred Forms
- 100 0 _ ‡a Boris Sepesi ‡c researcher
-
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer. | |
Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches. | |
Effects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database | |
Emerging Therapies in Thoracic Malignancies-Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non-Small Cell Lung Cancer | |
Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer. | |
Enhanced recovery after thoracic surgery is associated with improved adjuvant chemotherapy completion for non-small cell lung cancer | |
Enhanced Recovery Decreases Pulmonary and Cardiac Complications Following Thoracotomy for Lung Cancer. | |
Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy | |
Evolution of genomic and T cell repertoire heterogeneity of malignant pleural mesothelioma under dasatinib treatment | |
Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma | |
Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients | |
Genomic assessment distinguishes intrapulmonary metastases from synchronous primary lung cancers | |
Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization | |
High mutational concordance between primary colorectal tumors and associated pulmonary metastases | |
Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities | |
Immunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors. | |
Importance of resection for locoregional disease control in Masaoka stage IVA thymic neoplasms | |
Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer | |
The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer | |
The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma | |
The Influence of Reconstructive Technique on Perioperative Pulmonary and Infectious Outcomes Following Chest Wall Resection | |
Liposomal Bupivacaine Intercostal Block is Important for Reduction of Pulmonary Complications | |
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study | |
Local Recurrence After Microwave Ablation of Lung Malignancies: A Systematic Review | |
Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis. | |
Lung Cancer Patient Perceptions of the Value of an Outreach Thoracic Surgical Clinic | |
Matched Pairs Comparison of an Enhanced Recovery Pathway Versus Conventional Management on Opioid Exposure and Pain Control in Patients Undergoing Lung Surgery | |
Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma | |
Modified En bloc Esophagectomy Compared to Standard Resection after Neoadjuvant Chemoradiation | |
Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience | |
Multidisciplinary treatment of thymic neuroendocrine tumors: surgery remains a key component | |
Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm | |
Natural History of Ground Glass Lesions among Patients with Previous Lung Cancer. | |
Neoadjuvant Chemotherapy Increases Cytotoxic T cell, Tissue Resident Memory T cell and B Cell Infiltration in Resectable Non-Small Cell Lung Cancer | |
Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort | |
Omental reinforcement of the thoracic esophagogastric anastomosis: an analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy | |
Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience | |
Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy | |
Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women | |
Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel. | |
Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively | |
Persistent Opioid Use Among the Elderly After Lung Resection: A SEER-Medicare Study | |
Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer | |
Polytetrafluoroethylene or Acellular Dermal Matrix for Diaphragmatic Reconstruction? | |
Postoperative Bleeding and Acute Kidney Injury in Esophageal Cancer Patients Receiving Ketorolac | |
Predictors of survival after resection of primary sarcomas of the chest wall-A large, single-institution series | |
Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma. | |
Preoperative Heparin for Lung Cancer Resection Increases Risk of Reoperation for Bleeding | |
Prognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer. | |
Programmed Death Ligand 1 Heterogeneity and its Impact on Benefit from Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer | |
Przedziurawienie przełyku : strategie leczenia chirurgicznego, endoskopowego i zachowawczego | |
Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer | |
Reply to S.E. Vogl. | |
Results of Postdischarge Nursing Telephone Assessments: Persistent Symptoms Common Among Pulmonary Resection Patients | |
Return to intended oncologic treatment after surgery for malignant pleural mesothelioma | |
Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience | |
SABR vs surgery for NSCLC in the media | |
Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients | |
Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells. | |
Should endoscopic mucosal resection be attempted for cT2N0 esophageal cancer? | |
Single-cell analysis of human lung epithelia reveals concomitant expression of the SARS-CoV-2 receptor ACE2 with multiple virus receptors and scavengers in alveolar type II cells | |
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC). | |
Stage I lung cancer-to operate or to radiate? that is the question | |
Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases | |
Surgical therapy of ground-glass opacities | |
Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization | |
Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location | |
TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence. | |
Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients | |
TRACERx: Tracking tumor evolution to impact the course of lung cancer. | |
Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice | |
TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models. | |
Typical and atypical carcinoid tumors of the lung: a clinicopathological correlation of 783 cases with emphasis on histological features | |
Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing. |